Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Alteration”

15 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 15 of 15 results

Not applicableStudy completedNCT06514924
What this trial is testing

Secular Change of Height in Turkish Young Adults

Who this might be right for
Growth AlterationObesity
Istanbul University 465
Testing effectiveness (Phase 2)Active Not RecruitingNCT04595747
What this trial is testing

Testing the Anti-cancer Drug, Rogaratinib (BAY 1163877), for Treatment of Advanced Sarcoma With Alteration in Fibroblast Growth Factor Receptor (FGFR 1-4), and in Patients With SDH-deficient Gastrointestinal Stromal Tumor (GIST)

Who this might be right for
Locally Advanced Gastrointestinal Stromal TumorLocally Advanced SarcomaMetastatic Gastrointestinal Stromal Tumor+5 more
National Cancer Institute (NCI) 48
Testing effectiveness (Phase 2)Looking for participantsNCT04962867
What this trial is testing

NCCH2006/MK010 Trial (FORTUNE Trial)

Who this might be right for
Advanced or Recurrent Solid TumorsFGFR Gene Alterations
National Cancer Center, Japan 75
Early research (Phase 1)Study completedNCT03235570
What this trial is testing

A Safety and Tolerability Study of Pemigatinib in Japanese Subjects With Advanced Malignancies - (FIGHT-102)

Who this might be right for
Solid Tumors
Incyte Corporation 44
Not applicableUnknownNCT03363802
What this trial is testing

Assessment of Pubertal Growth Spurt in Growing Girls Using Middle Phalynx Finger and Correlate With Mandibular Second Molar

Who this might be right for
Growth Alteration
Cairo University 1,600
Testing effectiveness (Phase 2)Study completedNCT05253807
What this trial is testing

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
Incyte Corporation 8
Not applicableStudy completedNCT02168322
What this trial is testing

Perforated Barrier Membranes Maintain Physiologic Gingival Crevicular Fluid Growth Factor Levels

Who this might be right for
Vascular Endothelial Growth Factor OverexpressionMembrane Alteration
Al-Azhar University 30
Not applicableStudy completedNCT02958735
What this trial is testing

Exercise and Cognition Trials

Who this might be right for
Alteration of Cognitive Function
Johns Hopkins University 60
Early research (Phase 1)Ended earlyNCT01948297
What this trial is testing

Debio 1347-101 Phase I Trial in Advanced Solid Tumours With Fibroblast Growth Factor Receptor (FGFR) Alterations

Who this might be right for
Solid Tumours
Debiopharm International SA 77
Not applicableStudy completedNCT01143233
What this trial is testing

Low-protein Infant Formula With Partial or Extensive Proteinhydrolysate 4 Year Follow-up

Who this might be right for
Disturbance of Growth
HiPP GmbH & Co. Vertrieb KG 503
Not applicableNot Yet RecruitingNCT07515248
What this trial is testing

Catch up Growth Of Children After Closure Of Hemodinamically Significant Large VSD In Assuit University Children Hospital

Who this might be right for
Growth Alteration
Assiut University 58
Early research (Phase 1)Active Not RecruitingNCT04913285
What this trial is testing

Evaluate KIN-2787 in Participants With BRAF and/or NRAS Mutation Positive Solid Tumors

Who this might be right for
Solid Tumor, AdultNon-small Cell Lung CancerMelanoma
Pierre Fabre Medicament 400
Early research (Phase 1)Active Not RecruitingNCT05222802
What this trial is testing

Evaluate ERAS-801 in Patients With Recurrent Glioblastoma (THUNDERBBOLT-1)

Who this might be right for
Glioblastoma Multiforme
Katmai Pharmaceuticals Inc. 52
Not applicableLooking for participantsNCT06580639
What this trial is testing

The Role of a Mycobacterium Growth Inhibition Assay to Quantify Host Immune Control of M. Tuberculosis

Who this might be right for
TuberculosisImmunologic Activity Alteration
Linkoeping University 280
Testing effectiveness (Phase 2)Active Not RecruitingNCT05544552
What this trial is testing

Safety and Preliminary Anti-Tumor Activity of TYRA-300 in Advanced Urothelial Carcinoma and Other Solid Tumors With FGFR3 Gene Alterations

Who this might be right for
Locally Advanced Urothelial CarcinomaMetastatic Urothelial CarcinomaSolid Tumor+11 more
Tyra Biosciences, Inc 310